Improving Healthcare Value in Patients With Stage III-IVb Squamous Cell Carcinoma of Head and Neck (HNSCC): Comparative Effectiveness of 2 Arms of a Randomized, Phase 3 Trial of Definitive Chemoradiation (ChemoRT): Definitive Management of Head-and-Neck Squamous Cell Carcinoma.

MLA

Greskovich, J. F., et al. “Improving Healthcare Value in Patients With Stage III-IVb Squamous Cell Carcinoma of Head and Neck (HNSCC): Comparative Effectiveness of 2 Arms of a Randomized, Phase 3 Trial of Definitive Chemoradiation (ChemoRT): Definitive Management of Head-and-Neck Squamous Cell Carcinoma.” International Journal of Radiation Oncology, Biology, Physics, vol. 88, no. 2, Feb. 2014, pp. 466–67. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2013.11.025.

APA

Greskovich, J. F., Gordian, M., Lorenz, R., Scharpf, J., Khan, M., Burkey, B., Ives, D., Nwizu, T., Koyfman, S., & Adelstein, D. (2014). Improving Healthcare Value in Patients With Stage III-IVb Squamous Cell Carcinoma of Head and Neck (HNSCC): Comparative Effectiveness of 2 Arms of a Randomized, Phase 3 Trial of Definitive Chemoradiation (ChemoRT): Definitive Management of Head-and-Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology, Biology, Physics, 88(2), 466–467. https://doi.org/10.1016/j.ijrobp.2013.11.025

Chicago

Greskovich, J.F., M. Gordian, R. Lorenz, J. Scharpf, M. Khan, B. Burkey, D. Ives, T. Nwizu, S. Koyfman, and D. Adelstein. 2014. “Improving Healthcare Value in Patients With Stage III-IVb Squamous Cell Carcinoma of Head and Neck (HNSCC): Comparative Effectiveness of 2 Arms of a Randomized, Phase 3 Trial of Definitive Chemoradiation (ChemoRT): Definitive Management of Head-and-Neck Squamous Cell Carcinoma.” International Journal of Radiation Oncology, Biology, Physics 88 (2): 466–67. doi:10.1016/j.ijrobp.2013.11.025.